Comparison 31. Chinese BNHS versus glucosamine sulphate.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Pain VAS 0‐100 (walking) | 1 | 60 | Mean Difference (IV, Random, 95% CI) | ‐2.0 [‐6.81, 2.81] |
2 WOMAC‐VAS (Function) | 1 | 60 | Mean Difference (IV, Random, 95% CI) | 0.0 [‐2.53, 2.53] |
3 Participants (n) reported adverse events | 1 | 60 | Risk Ratio (M‐H, Random, 95% CI) | 9.00 [0.51, 160.17] |